Market Intelligence

Our team are dedicated to different therapy areas, allowing them to develop a broad knowledge and awareness of current trends that greatly assists in identifying insights for each client project.

In 2024, the team delivered 31 projects in 14 markets, collecting the evidence base to make informed decisions in the following areas:

• Thoraco-abdominal endovascular devices

• Left Ventricular Assist Devices

• Peripheral vascular disease

  • Venous stent

  • Above-The-Knee interventions

  • Below-The-Knee interventions

  • Intravascular lithotripsy

• Dialysis access creation and revision

• Left atrial appendage occluders

• Liquid embolic agents

• Liver interventions

  • Endoscopic and endovascular TIPS

  • TICE (Transarterial Intrahepatic Chemoembolization Evaluation)

• Surgical closure devices

• Surgical accessories

• Hemostasis devices

• Cystoscopy

• Tumour ablation

• Oncology pancreatic and breast

  • Immunotherapy

  • KRAS inhibitors

  • Antibody-drug conjugates

• Hemophilia and inhibitors

• Urology endoscopy imaging and access

Across the team we have over 50 years experience in medical research in different settings from academia, public health and business consulting. In the past, we’ve worked across vaccines, pharmaceutical and international public health.

Projects delivered in 2024, include: